ATPW
NUVB icon

Ashton Thomas Private Wealth’s Nuvation Bio NUVB Stock Holding History

Ashton Thomas Private Wealth’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-73,302
Closed -$271K – 1038
2025
Q3 		$271K Buy
73,302
+6,047
+9% +$16.5K 0.01% 835
2025
Q2 		$131K Buy
+67,255
New +$140K ﹤0.01% 813

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Ashton Thomas Private Wealth's NUVB Position: Q4 2025 in Review

Ashton Thomas Private Wealth sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 73,302 shares — an estimated $271K sold.

Ashton Thomas Private Wealth first reported a position in NUVB in Q2 2025 and held it in 2 quarters. The position peaked at $271K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Ashton Thomas Private Wealth reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 73,302 Nuvation Bio shares in Q4 2025, an estimated $271K.
  • Ashton Thomas Private Wealth first reported a position in Nuvation Bio in Q2 2025 and held it in 2 quarters.
  • Ashton Thomas Private Wealth's Nuvation Bio position peaked at $271K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Ashton Thomas Private Wealth's 13F filing for Q4 2025, filed 29 Jan 2026.